Percutek Therapeutics
Aortic repair, minimally invasive
Beijing, China
Percutek Therapeutics develops and manufactures medical devices, such as stent-grafts, for the non-invasive interventional diagnosis and treatment of cardiovascular diseases.
How We Help
Problem Statement
To address the need for high-quality products and solutions in non-invasive interventional cardiovascular diagnosis and treatment for various vascular diseases.
Core Technology
Stent-grafts designed with special weaving techniques that reduce membrane penetration force while maintaining structural integrity.
Key Differentiators
Proprietary weaving techniques for stent-grafts that reduce membrane penetration force while maintaining structural integrity.
Clinical Focus
Cardiology; Interventional Radiology
Company Info
- Business Model
- B2B
- Total Funding
- 39,500,000
- Website
- www.huamaitaike.com
Categories
Technologies
Clinical & IP
Clinical Validation
First-in-human case published in European Heart Journal (2024) demonstrating successful TEVAR with in situ fenestration. Clinical trial data shows 95.8% success rate for AAA repair. SIS graft in multicenter clinical trials. Published in peer-reviewed journals.
MedStartr Index Score
?What do you think of Percutek Therapeutics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.